TNF and Opportunistic infection: Some of these novel drugs not only offer a potential solution for CD patients facing resistance to TNF-\begin{document}\alpha\end{document} inhibitors but may also provide a superior alternative for individuals prone to opportunistic infections or the adverse effects associated with existing treatments.